|
|
|
Volumn 25, Issue 12, 2011, Pages
|
|
EMCC: Oral anti-angiogenesis treatment plus chemotherapy is not more efficacious than bevacizumab plus chemotherapy in metastatic colorectal cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
FLUOROURACIL;
FOLINIC ACID;
NINTEDANIB;
ANTIANGIOGENIC ACTIVITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
COLORECTAL CANCER;
COMPARATIVE EFFECTIVENESS;
DIGESTIVE SYSTEM PERFORATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
GASTROINTESTINAL SYMPTOM;
HUMAN;
HYPERTENSION;
METASTASIS;
NOTE;
OUTCOME ASSESSMENT;
OVERALL SURVIVAL;
PROGRESSION FREE SURVIVAL;
QUALITY OF LIFE;
SIDE EFFECT;
|
|
EID: 84855616242
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
